Spruce Biosciences
Clinical trials sponsored by Spruce Biosciences, explained in plain language.
-
PCOS drug trial halted early: did tildacerfont lower hormones?
Disease control TerminatedThis study tested a drug called tildacerfont in women with polycystic ovary syndrome (PCOS) who had high levels of adrenal androgens (a type of hormone). The goal was to see if the drug could safely lower these hormone levels. The study enrolled 27 women aged 18 to 40 and was ter…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 17, 2026 12:54 UTC
-
New drug aims to cut steroid use in rare hormone disorder
Disease control TerminatedThis study tested a drug called Tildacerfont in 100 adults with classic congenital adrenal hyperplasia, a condition where the body can't make certain hormones properly. The goal was to see if it could safely lower the high doses of steroids patients need to take. The study was st…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control TerminatedThis study tested a drug called tildacerfont in children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a condition where the body can't make certain hormones properly. The goal was to see if the drug is safe and can help control the disease while allowing children to ta…
Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC